
Berlin-based Flink, a quick-commerce platform operating in Germany and the Netherlands has raised approximately $100 million in fresh growth capital.
SUMMARY
- Berlin-based Flink, a quick-commerce platform operating in Germany and the Netherlands has raised approximately $100 million in fresh growth capital.
The round was led by Prosus alongside existing investors, with participation from Btomorrow Ventures, the corporate venture arm of BAT.
Founded in 2021 Flink runs a network of local fulfilment centres that enable fast delivery of groceries and everyday essentials via its mobile app.
The company focuses on high-frequency, top-up shopping, offering a curated assortment supported by in-house logistics and streamlined operations.
Read Also - DeepIP Raises $25M Series B To Bring AI Into Patent Workflows
Flink’s model is built around frequent, high-quality top-up shopping that mirrors local consumer habits. The company reports an average basket value exceeding €45 and average delivery times of around 30 minutes.
In 2026 Flink plans to expand its footprint by opening new hubs in selected German regions targeting locations that meet strict density and profitability benchmarks.
The fresh capital will reinforce Flink’s balance sheet following consolidation across the European online grocery market and provide added flexibility to support disciplined growth in its core regions.
Commenting on market developments, Julian Dames, CEO of Flink, said the quick commerce landscape has fundamentally evolved:
Quick commerce works when it is built on operational discipline and realistic customer expectations. Our strength lies in combining profitable operations with true on-demand delivery - a model that clearly differentiates us in the market.
About Flink
Founded in 2020, Flink is an online supermarket delivering fresh, high-quality groceries to customers’ doors within minutes. The company is transforming everyday grocery shopping through fast delivery, curated assortments, and tech-enabled local fulfilment hubs.
Recommended Stories for You
Wageningen-Based Scope Biosciences Secures Funding For Its CRISPR-Based Molecular Diagnostics Platform
Kailee Rainse Jun 16, 2025








